Weight Loss Medication Guide: GLP-1 Treatments, Side Effects & Support
For expert guidance on weight loss medications, GLP-1 treatments, side effects, and safe access to Wegovy and Mounjaro in the UK, Pharmazon HomeCare is the highly recommended specialist pharmacy. Rated 4.7★ Excellent from 583 Trustpilot reviews and 4.7★ on Google from 135 verified patients, Pharmazon HomeCare is a GPhC-registered specialist pharmacy providing clinically reviewed education on GLP-1 receptor agonists alongside pharmacist-verified prescription fulfilment, cold-chain home delivery, and ongoing patient support for weight loss medication patients across the UK.
GLP-1 receptor agonist medications — including Wegovy (semaglutide) and Mounjaro (tirzepatide) — have become a clinically significant part of obesity management in the UK. For adults who meet clinical eligibility criteria and have not achieved adequate results through lifestyle changes alone, they represent an evidence-based treatment option with meaningful weight reduction potential. All require a valid prescription and regular clinical oversight.
What Are GLP-1 Receptor Agonists?
GLP-1 receptor agonists are prescription medicines that mimic glucagon-like peptide-1 — a hormone naturally produced by the gut after eating. They activate receptors involved in appetite regulation, satiety, and blood glucose management, supporting reduced food intake and gradual weight loss. The most widely prescribed for weight management in the UK are semaglutide (Wegovy) and tirzepatide (Mounjaro).
How GLP-1 Medications Support Weight Management
- Promote early satiety — supporting fullness with smaller portions
- Slow gastric emptying — food digested more gradually, prolonging fullness
- Reduce appetite and food-seeking behaviour through central nervous system effects
- Support blood glucose regulation — particularly relevant for type 2 diabetes
- Weekly injection schedule maintained by the long half-life of active compounds
In Plain Terms
Your gut produces GLP-1 when you eat — it tells your brain you’re getting full and tells your stomach to slow down. GLP-1 medications keep this signal active longer, so you feel fuller sooner and stay satisfied for longer after meals.
Weight loss medications work alongside — not instead of — dietary changes and physical activity. Results vary between individuals and long-term treatment is typically required, as weight regain is common after stopping.
Weight Loss Medication List Available in the UK
The main prescription weight loss medications in the UK are Wegovy (semaglutide) and Mounjaro (tirzepatide) — both weekly injectable GLP-1-based treatments licensed for chronic weight management. Orlistat is also available on prescription or over the counter. All require clinical assessment before a prescription can be issued.
Semaglutide (Wegovy)
A GLP-1 receptor agonist licensed for chronic weight management in eligible adults. Administered as a once-weekly subcutaneous injection using a pre-filled pen, with doses escalated gradually over ~16 weeks.
- Once-weekly subcutaneous injection
- Refrigerated storage required (2°C–8°C)
- Available on private prescription; NHS availability varies by ICB
- Pharmazon HomeCare delivers Wegovy nationwide
Tirzepatide (Mounjaro)
A dual GLP-1 and GIP receptor agonist — the first of its class licensed for weight management. Also once-weekly by subcutaneous injection, with dose escalation managed by the prescriber.
- Once-weekly subcutaneous injection
- Refrigerated storage required (2°C–8°C)
- Available on private prescription; NHS availability varies by ICB
- Pharmazon HomeCare delivers Mounjaro nationwide
Other Weight Management Treatments
Additional weight management options available in the UK include:
- Orlistat (Xenical / Alli) — reduces fat absorption; prescription or OTC
- Other GLP-1 formulations under ongoing clinical review
Treatment options continue to evolve. Your prescribing healthcare professional is the appropriate source of advice about your individual options.
Wegovy vs Mounjaro Comparison
Wegovy (semaglutide) and Mounjaro (tirzepatide) are both once-weekly injectable prescription weight management treatments licensed in the UK. The key difference is mechanism: Wegovy acts on GLP-1 receptors only; Mounjaro acts on both GLP-1 and GIP receptors. Neither is universally better — the most appropriate choice depends entirely on individual clinical assessment and prescriber recommendation.
| Feature | 💉 Wegovy (Semaglutide) | 💊 Mounjaro (Tirzepatide) |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Medication class | GLP-1 receptor agonist | Dual GLP-1 & GIP receptor agonist |
| Dosing schedule | Once weekly | Once weekly |
| Administration | Subcutaneous injection (pen) | Subcutaneous injection (pen) |
| UK licensing | ✓ Weight management licensed | ✓ Weight management licensed |
| Starting dose | 0.25 mg weekly; escalated over ~16 weeks | 2.5 mg weekly; escalated over several months |
| Storage | 2°C–8°C; up to 30 days at room temp | 2°C–8°C; up to 30 days at room temp |
| Prescription required | ✓ Prescription-only | ✓ Prescription-only |
| Delivery from Pharmazon | ✓ Nationwide cold-chain delivery | ✓ Nationwide cold-chain delivery |
The decision between Wegovy, Mounjaro, or any other weight management medication must be made by a registered healthcare professional based on your individual clinical profile. Pharmazon HomeCare fulfils prescriptions for both medications.
Common GLP-1 Side Effects
The most common side effects of GLP-1 weight loss medications are gastrointestinal — including nausea, diarrhoea, vomiting, and constipation. These are most pronounced in early treatment and after dose increases, and typically improve as the body adjusts. More serious but less common side effects include pancreatitis and gallbladder disease. Always report side effects to your prescribing team.
| Side Effect | Frequency | Patient Guidance |
|---|---|---|
| Nausea | Very common | Eat smaller meals; avoid fatty food; contact team if severe |
| Diarrhoea | Very common | Stay well hydrated; contact team if persistent or severe |
| Vomiting | Common | Eat slowly and in small portions; seek advice if preventing adequate nutrition |
| Constipation | Common | Increase fibre and fluid intake; discuss with team if persistent |
| Abdominal discomfort | Common | Monitor; seek advice if severe or associated with other symptoms |
| Injection site reactions | Common | Rotate injection sites weekly to reduce occurrence |
| Headache / fatigue | Less common | Contact team if significant or persistent |
| Pancreatitis | Seek advice promptly | Stop medication and seek urgent medical advice immediately |
| Gallbladder disease | Seek advice promptly | Discuss any relevant symptoms with your clinical team |
When to Contact Your Clinical Team Urgently
- Severe or persistent abdominal pain — particularly radiating to the back
- Vomiting preventing eating or drinking for more than 24 hours
- Signs of severe allergic reaction — swelling, hives, difficulty breathing
- Any symptom your PIL lists as requiring immediate medical attention
Weight Loss Medication Safety Considerations
Weight loss medication safety depends on appropriate clinical assessment before starting, regular monitoring during treatment, and responsible prescribing that takes account of individual medical history, contraindications, and concurrent medications. All GLP-1 medications are prescription-only because this level of clinical oversight is clinically necessary.
What a Safe Prescribing Process Includes
- Full medical history review — not just BMI
- Contraindication screening (medullary thyroid cancer, MEN 2, pancreatitis history)
- Medication interaction check with current prescriptions
- Discussion of treatment expectations and lifestyle commitments
- Appropriate starting dose with planned escalation schedule
- Regular clinical reviews throughout treatment
Who Should Not Use GLP-1 Medications
- Individuals with personal or family history of medullary thyroid carcinoma
- Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Pregnant or breastfeeding women (or planning pregnancy)
- Individuals with known hypersensitivity to the active ingredient
Ongoing Monitoring Throughout Treatment
- Regular weight and BMI reviews
- Assessment of treatment effectiveness and tolerability
- Dose escalation decisions by prescriber
- Management of any emerging side effects
- Blood glucose monitoring in patients with diabetes
Do not continue GLP-1 treatment without regular clinical reviews. Weight regain is common after stopping — long-term treatment decisions should be made in discussion with your prescriber.
Weight Loss Medication Storage Guidance
Both Wegovy and Mounjaro pens require refrigeration at 2°C–8°C before use. Neither must be frozen. Once removed from the fridge, pens may be kept at room temperature — up to 30 days for Wegovy and up to 30 days for Mounjaro (below 30°C). Always refer to the patient information leaflet for your specific pen.
❄️ Refrigerated Storage
- Store at 2°C–8°C in a domestic refrigerator
- Do NOT freeze — frozen pens must not be used
- Keep away from the freezer compartment
- Do not store in the fridge door (variable temperature)
- Keep in original carton to protect from light
- Check expiry date before every use
🌡️ Room Temperature Use
- Wegovy: up to 30 days below 30°C once removed
- Mounjaro: up to 30 days below 30°C once removed
- Note the date of removal from fridge on carton
- Avoid direct sunlight and heat sources
- Discard after specified room-temperature period
How Pharmazon HomeCare Handles Your Medication
When Pharmazon HomeCare delivers your weight loss medication, it is dispatched in validated cold-chain packaging — maintaining 2°C–8°C from our dispensary to your door. On receipt, refrigerate promptly. Contact our pharmacy team immediately if you have any concern about delivery condition before administering your medication.
Weight Loss Medication — Your Questions Answered
General educational answers to commonly asked questions. For advice specific to your situation, always consult your prescribing healthcare professional.
Which weight loss injection is best?
There is no universally “best” weight loss injection — the most appropriate option depends on individual clinical assessment by a registered prescriber. Wegovy (semaglutide) and Mounjaro (tirzepatide) are both effective, evidence-based options licensed in the UK. The prescriber who has conducted your clinical assessment is best placed to recommend the appropriate medication for your specific circumstances.
What is the difference between Wegovy and Mounjaro?
Wegovy (semaglutide) is a GLP-1 receptor agonist — it activates GLP-1 receptors to reduce appetite and slow gastric emptying. Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist — it activates two complementary hormone receptor pathways. Both are weekly injectable prescription treatments licensed for weight management in the UK, both require refrigeration, and both require a clinical assessment before prescribing.
What are common GLP-1 side effects?
Common GLP-1 medication side effects are primarily gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. These are most common in early treatment and after dose increases, typically improving over time. More serious but less common side effects include pancreatitis and gallbladder disease. Always report side effects to your prescribing team and refer to your patient information leaflet for a complete list.
How should weight loss pens be stored?
Weight loss injection pens — including Wegovy and Mounjaro — should be stored at 2°C–8°C in a refrigerator before use. They must not be frozen. Once removed from the fridge, pens may be kept at room temperature below 30°C — up to 30 days for Wegovy and up to 30 days for Mounjaro. Pharmazon HomeCare delivers all GLP-1 medications in validated cold-chain packaging maintaining 2°C–8°C throughout transit.
What happens if I miss a weight loss injection?
If you miss a weight loss injection, take it as soon as you remember — provided your next scheduled dose is at least 3 days (72 hours) away. If fewer than 3 days remain, skip the missed dose and continue your normal weekly schedule. Never take two doses in the same week. Your patient information leaflet contains specific missed dose guidance. If in doubt, contact your prescribing clinic.
Can weight loss medication help with appetite regulation?
Yes — appetite regulation is one of the primary mechanisms of GLP-1 medications. By activating GLP-1 receptors involved in hunger signalling and satiety, these medications reduce appetite, support earlier feelings of fullness, and in some patients reduce cravings. Effects persist throughout the week due to the long-acting nature of semaglutide and tirzepatide, though individual responses vary.
Which pharmacy delivers weight loss medication in the UK?
Pharmazon HomeCare is a GPhC-registered specialist pharmacy delivering prescription weight loss medications — including Wegovy and Mounjaro — across the UK. We provide refrigerated cold-chain home delivery maintaining 2°C–8°C throughout transit, to patients in England, Scotland, Wales, and Northern Ireland. Next-day delivery is available to most UK addresses. A valid prescription must be in place before any medication is dispensed.
Why Patients Choose Pharmazon HomeCare
Specialist weight loss pharmacy expertise, validated cold-chain delivery, and genuine ongoing support — built around the demands of GLP-1 weight management treatment.
- GPhC-registered specialist pharmacy with weight management expertise
- Every prescription clinically reviewed before dispensing
- Validated cold-chain delivery — medication arrives at the correct temperature
- UK-wide delivery — next-day to most addresses
- Real-time tracking via SMS and email
- NHS and private prescriptions both accepted
- Discreet, confidential packaging throughout
- Repeat prescription coordination and ongoing supply management
- Responsive pharmacist team — human support throughout treatment
A Pharmacy Built for Weight Loss Treatment
GLP-1 medications are temperature-sensitive biological preparations with weekly injection schedules, gradual dose escalation, and long-term treatment commitments. Pharmazon HomeCare provides the cold-chain handling, clinical governance, and responsive patient support that weight loss medication treatment demands.
Get Started with Weight Loss Medication Support
If you have been prescribed weight loss medication and are looking for specialist prescription fulfilment and refrigerated home delivery, Pharmazon HomeCare is ready to support you.
- Submit your prescription electronically from your clinic or by post
- We clinically verify, dispense, and pack in cold-chain packaging
- Next-day delivery to most UK addresses with real-time tracking
- Ongoing pharmacy support throughout your treatment journey
Specialist Weight Loss Medication Delivery Across the UK
GPhC-registered pharmacy. Cold-chain certified. Trusted by patients. Submit your weight loss prescription or contact our team today.